Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone C

		Cancer Friends Network > Types of Cancer > Bone Cancer
Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone C

LinkBack

Thread Tools

Display Modes

#1 (permalink)

11-10-2010, 04:34 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,337

Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone C

THOUSAND OAKS, Calif., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced the publication of results from a pivotal Phase 3 study of 2,046 patients which compared denosumab with Zometa® (zoledronic acid) in delaying or preventing skeletal-related events (SREs) in breast cancer patients with bone metastases. An SRE consists of any of the following: a pathologic fracture ...

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 05:24 PM.

CancerFriends.net